Growing Demand for NGS Service and Rising Investment by Key Players
The next generation sequencing (NGS) informatics services have gained popularity in the recent years, owing to the growth in demand for the NGS services in screening and early detection of chronic diseases, globally. Adoption of informatics tools in NGS has led to a reduction in cost and quick turnaround time, which has propelled the uptake of NGS services over the traditional microarray, capillary electrophoresis (CE), and Sanger methods. This factor is likely to drive the demand for NGS service in the detection of chronic diseases, such as cancers, diabetes, chronic kidney disease, and cardiovascular disease, among others. Increasing investment from private players toward the development of new low-cost NGS systems and development of novel software tools in analysis and interpretation have further augmented the growth of NGS informatics service market. In addition, increase in clinical applications of NGS, technological advancement in NGS informatics tools, rising preference toward personalized medicines are the factors fuelling the next generation sequencing informatics market.
Lack of Skilled Technicians
The inadequacy of skilled professionals for analysis and data interpretations of NGS data and the lack of knowledge of new informatics tools among medical professionals are likely to limit the growth of next generation sequencing informatics market. Additionally, high cost, involved in maintenance and security of informatics tools, is likely to restrict the growth of NGS informatics market.
Lack of reimbursement, ethical challenges, and the high cost of some advanced next generation sequencing systems and tools are likely to restrain the market growth.
North America to Dominate the Market
The next generation sequencing informatics market has been segmented on the basis of service type, application, end user, and geography. By geography, this market has been segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Due to the presence of well-established healthcare facilities and the growth in demand for high-speed informatics tools, owing to the launch of high-throughput sequencing equipment and population-scale genome sequencing projects in the region, North America is dominating the next generation sequencing informatics market. The Asia-Pacific next generation sequencing informatics market is also expected to grow owing to the factors, such as increasing accessibility to healthcare facilities in the region, rising rate of adoption of next generation sequencing in drug discovery, growing investment from public and private sectors for genome sequencing projects, and the entrance of global players in this lucrative market.
Key Developments in the Market
- January 2018: Genomics England adopted Edico's Dragen Bio-IT platform, to address alignment and variant calling of whole-genome sequencing data.
- October 2017: Bluebee, and Pacific Biosciences of California, Inc., the leader in long-read sequencing, announced the integration of the PacBio de novo assembly pipeline onto the Bluebee genomics analysis platform. The integration creates a simplified workflow and a fully automated, end-to- end data analysis solution that allows assembly of any size genome, including the human genome.
Reasons to Purchase this Report
- Current and future global next generation sequencing market outlook in the developed and emerging markets
- Various perspectives of the market, with the help of Porter’s five forces analysis
- The segment expected to dominate the market
- The region expected to witness the fastest growth rate during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in excel)
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product & Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Clinical Application of NGS
6.1.2 Technological Advancement in NGS Informatics Tools
6.1.3 Growing Preference towards Personalized Medicines & Early Disease Diagnosis
6.1.4 Growing Demand for NGS Service and Rising Investment by Key Players
6.2 Market Restraints
6.2.1 Lack of Skilled Technicians for NGS Informatics Services
6.2.2 High Cost of NGS Sequencing
6.4 Key Challenges
7. Market Segmentation
7.1 By Service
7.1.1 NGS Sequencing Informatics Tools
7.1.2 Data Analysis Tools
7.1.3 Storage and Computing Tools
7.1.4 Interpretation and Reporting Tools
7.1.5 Laboratory Information Management System (LIMS)
7.2 By Application
7.2.1 Drug Discovery
7.2.2 Genetic Screening
7.2.3 Diseases Diagnosis
7.2.4 Precision Medicines
7.3 By End User
7.3.1 Hospitals and Clinics
7.3.2 Academics and Research Institutes
7.3.3 Pharmaceuticals and Biotechnology Companies
7.4 By Geography
7.4.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest Of Europe
18.104.22.168 Australia & New Zealand
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
7.4.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of the Middle East & Africa
7.4.5 South America
220.127.116.11 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Amazon Web Services LLC
9.2 Dnanexus Inc.
9.3 F. Hoffmann-La Roche Ltd
9.4 Genomatrix AG
9.5 Illumina Inc.
9.6 Omicia Inc.
9.7 Partek Incorporated
9.8 Qiagen NV
9.9 Sapio Sciences
9.10 Thermo Fischer Scientific Inc.
10. Future of the Market